Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

We have observed 5 EP applications Mark Frederic Paris Turner has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12730499

HCV COMBINATION THERAPY

IPC classification:
A61K 31/454, A61K 31/497, A61K 31/7056, A61K 31/7115, A61K 31/712, A61K 31/7125, A61P 31/14, C12N 15/113
Agent:
Mark Frederic Paris Turner, Santaris Pharma A/S
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12784565

PROGNOSTIC METHOD FOR CHECKING EFFICACY OF MICRO RNA-122 INHIBITORS IN HCV+ PATIENTS

IPC classification:
C12Q 1/70, G01N 33/576
Applicant:
Roche Innovation Center Copenhagen A/S
Agent:
Charles Thomas Harding, D Young & Co LLP
Agent:
Mark Frederic Paris Turner, Roche Innovation Center Copenhagen A/S
Status:
PATENT GRANTED
EP12191739

Micromirs

IPC classification:
A61K 31/7088, A61K 31/7115, A61K 31/712, A61P 3/06, A61P 31/14, C12N 15/11, C12N 15/113
Applicant:
Roche Innovation Center Copenhagen A/S
Agent:
Mark Frederic Paris Turner, Santaris Pharma A/S
Status:
EXAMINATION IN PROGRESS
EP12191738

Micromirs

IPC classification:
A61K 31/7105, A61K 31/7115, A61K 31/712, C12N 15/11, C12N 15/113
Applicant:
Roche Innovation Center Copenhagen A/S
Agent:
Mark Frederic Paris Turner, Santaris Pharma A/S
Status:
EXAMINATION IN PROGRESS
EP15701345

POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES

IPC classification:
C12N 15/113
Applicant:
F. Hoffmann-La Roche AG
Agent:
Mark Frederic Paris Turner, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature